Daewoong Pharmaceutical Co Ltd

069620

Company Profile

  • Business description

    Daewoong Pharmaceutical Co Ltd develops, manufactures and sells prescription drug products. The company's product portfolio comprises products such as Moxicle, Plunazol Cap, Bearcef tab, Newdizime etc. It develops and promotes brands such as Ursa, Nabota, Luphere, Easyef, Cretropin. The company has manufacturing facilities at Hyangnam and Sungnam.

  • Contact

    12, Bongeunsa-ro 114-gil
    Daewoong Pharmaceutical Building
    Gangnam-gu
    Seoul
    KOR

    T: +82 25508800

    https://www.daewoong.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    1,777

Stocks News & Analysis

stocks

Overvalued ASX mining giant

Solid start to 2026 but shares overvalued.
stocks

Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?

With recent structural changes and strong Azure performance, here’s what we think of Microsoft stock.
stocks

Tesla earnings: Shares fall as market focuses on uncertainty in near term

Are shares overpriced despite the fall?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,317.2026.50-0.28%
CAC 408,202.7823.00-0.28%
DAX 4024,240.2832.490.13%
Dow JONES (US)47,152.75418.140.89%
FTSE 1009,610.1931.620.33%
HKSE26,160.15192.170.74%
NASDAQ23,200.24258.451.13%
Nikkei 22549,299.65658.041.35%
NZX 50 Index13,391.5914.490.11%
S&P 5006,795.0356.590.84%
S&P/ASX 2009,019.0025.20-0.28%
SSE Composite Index3,950.3127.900.71%

Market Movers